8-K: FIGS Reports Strong Q1 2026 Results, Exceeds Expectations

FIGS, Inc. announced first quarter 2026 financial results, showcasing robust revenue growth, improved profitability, and an increased full-year outlook.

Summary

• FIGS, Inc. reported first quarter 2026 net revenues of $159.9 million, a 28.0% increase year-over-year.
• The company surpassed three million active customers for the first time, reaching 3.0 million.
• Net income was $6.3 million, or $0.03 per diluted share, a significant improvement from a net loss of $(0.1) million in the prior year.
• Adjusted EBITDA increased to $13.9 million, with a margin of 8.7%, up from 7.3% in the same period last year.
• The company raised its full-year 2026 outlook, now expecting net revenue growth of 14% to 16% and an Adjusted EBITDA margin of 13.0% to 13.2%.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, with the company exceeding expectations on key financial and operational metrics and raising its full-year guidance.

Positives

• Net revenues grew 28.0% year-over-year to $159.9 million.
• Active customers surpassed three million for the first time, reaching 3.0 million, a 12.2% increase year-over-year.
• Net income turned positive at $6.3 million ($0.03 per diluted share) compared to a net loss of $(0.1) million in Q1 2025.
• Adjusted EBITDA increased by $4.7 million to $13.9 million.
• Adjusted EBITDA margin improved to 8.7% from 7.3% in the prior year.
• Average order value (AOV) increased by 4.2% to $124.
• Full-year 2026 net revenue growth outlook increased to 14%-16%.
• Full-year 2026 Adjusted EBITDA margin outlook increased to 13.0%-13.2%.

Negatives

• Operating expenses increased by 22.6% year-over-year, though they decreased as a percentage of net revenues.
• Gross margin increased only slightly by 10 basis points to 67.7%, impacted by higher tariffs and product mix shift.
• Free cash flow was negative at $(5.6) million for the quarter.
• Cash and cash equivalents decreased from $81.9 million to $74.3 million during the quarter.

Risks

• Potential for increased tariffs impacting gross margin.
• Product mix shift potentially affecting gross margin.
• Higher marketing expenses related to the 2026 Winter Olympics campaign.
• Risks associated with expansion into international markets.
• Fluctuating costs of raw materials.
• Impact of global trade policy on sourcing and distribution.
• Potential for cyberattacks and failure to protect customer data.
• Competition in the healthcare apparel market.

Future Outlook

The company raised its full-year 2026 outlook, now expecting net revenue growth between 14% and 16%, and an Adjusted EBITDA margin between 13.0% and 13.2%. For the second quarter of 2026, growth is expected in the low 20% range.

Management Comments

• "Our outperformance in the first quarter shows that our broad-based momentum from 2025 has continued into 2026."
• "Our excellent top line growth was driven by both acceleration in our active customer base, which surpassed three million for the first time in our history, and strong repeat dynamics."
• "We also paired our top line beat with upside to the bottom line, highlighting the structural advantage of our business model."
• "We believe our product, brand, and community strategies, combined with the substantial long-term tailwinds in healthcare, position us for continued success going forward."
• "Our strong start to 2026 fuels our confidence and supports higher net revenues and adjusted EBITDA margin expectations for the rest of the year."
• "Our improved bottom-line outlook reflects our top-line momentum and operational execution, enabling continued investments in growth while effectively managing higher freight surcharges."
• "Finally, our balance sheet remains a source of strength, positioning us to continue driving shareholder returns."

Industry Context

StockSavvy.ai notes that FIGS' strong performance in Q1 2026, particularly its revenue growth and active customer expansion, aligns with a broader trend of increasing demand for specialized and comfortable professional apparel within the healthcare sector. The company's direct-to-consumer model and focus on brand community appear to be effective strategies in this growing market.

Comparison to Industry Standards

• FIGS' Q1 2026 net revenue growth of 28.0% significantly outpaces the typical growth rates seen in the broader apparel retail sector, which has faced more moderate expansion.
• The Adjusted EBITDA margin of 8.7% for Q1 2026 demonstrates strong operational efficiency, though it may vary compared to highly specialized or vertically integrated competitors in niche markets.
• The active customer growth of 12.2% and net revenue per active customer increase of 5.8% suggest effective customer acquisition and retention strategies, potentially outperforming general e-commerce platforms.

Stakeholder Impact

• Shareholders: Positive impact due to improved financial performance, increased profitability, and raised full-year outlook, potentially leading to stock price appreciation.
• Employees: Continued investment in growth may lead to expansion and new opportunities, though increased marketing expenses could impact short-term profitability.
• Customers: Continued focus on product, brand, and community strategies aims to enhance customer experience and loyalty.
• Suppliers: Increased demand from revenue growth may lead to higher order volumes, but potential impacts from global trade policy and raw material costs remain.

Next Steps

• Continue to invest in growth initiatives.
• Effectively manage higher freight surcharges.
• Continue to drive shareholder returns.
• Focus on Q2 2026 growth, expected in the low 20% range.

Key Dates

Recommendation

The company demonstrated strong top-line and bottom-line performance, exceeding expectations and raising its full-year guidance. The significant growth in active customers, improved margins, and positive net income, coupled with a robust outlook, indicate a company executing well in a growing market. This performance warrants a strong buy recommendation for investors seeking growth.

Keywords

FIGS, Healthcare Apparel, Q1 2026 Earnings, Financial Results, Revenue Growth, Profitability, Active Customers, Adjusted EBITDA